Recombinant-follicle stimulating hormone (r-FSH)
Pre-clinicalTerminated 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Multifollicular Stimulation
Conditions
Multifollicular Stimulation
Trial Timeline
Feb 1, 2009 → Feb 1, 2010
NCT ID
NCT01080729About Recombinant-follicle stimulating hormone (r-FSH)
Recombinant-follicle stimulating hormone (r-FSH) is a pre-clinical stage product being developed by Merck for Multifollicular Stimulation. The current trial status is terminated. This product is registered under clinical trial identifier NCT01080729. Target conditions include Multifollicular Stimulation.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01080729 | Pre-clinical | Terminated |
Competing Products
1 competing product in Multifollicular Stimulation
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Gonal-F (Follitropin alfa) | Merck | Pre-clinical | 23 |